(NASDAQ: XRAY) Dentsply Sirona's forecast annual revenue growth rate of 1.82% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.5%.
Dentsply Sirona's revenue in 2025 is $3,624,000,000.On average, 18 Wall Street analysts forecast XRAY's revenue for 2025 to be $741,535,116,804, with the lowest XRAY revenue forecast at $706,214,418,291, and the highest XRAY revenue forecast at $771,667,464,123. On average, 18 Wall Street analysts forecast XRAY's revenue for 2026 to be $747,322,123,905, with the lowest XRAY revenue forecast at $694,241,300,151, and the highest XRAY revenue forecast at $789,228,037,395.
In 2027, XRAY is forecast to generate $765,481,353,084 in revenue, with the lowest revenue forecast at $711,003,665,547 and the highest revenue forecast at $818,362,624,869.